Evidence map›Paper›PMID 37946211›Full record

ArticleJournal of neuroinflammation2023

M2 macrophage-derived cathepsin S promotes peripheral nerve regeneration via fibroblast-Schwann cell-signaling relay.

Eri Oshima, Yoshinori Hayashi, Zhen Xie, Hitoshi Sato, Suzuro Hitomi, Ikuko Shibuta, Kentaro Urata, Junjun Ni, Koichi Iwata, Tatsuo Shirota and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Eri OshimaDepartment of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2-1-1 Kitasenzoku, Ota-ku, Tokyo, 142-8515, Japan.
Yoshinori HayashiDepartment of Physiology, Nihon University School of Dentistry, 1-8-13, Kandasurugadai, Chiyoda-Ku, Tokyo, 101-8310, Japan. hayashi.yoshinori@nihon-u.ac.jp.
Zhen XieKey Laboratory of Molecular Medicine and Biotherapy in the Ministry of Industry and Information Technology, Department of Biology, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.
Hitoshi SatoDepartment of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2-1-1 Kitasenzoku, Ota-ku, Tokyo, 142-8515, Japan.
Suzuro HitomiDepartment of Physiology, Nihon University School of Dentistry, 1-8-13, Kandasurugadai, Chiyoda-Ku, Tokyo, 101-8310, Japan.
Ikuko ShibutaDepartment of Physiology, Nihon University School of Dentistry, 1-8-13, Kandasurugadai, Chiyoda-Ku, Tokyo, 101-8310, Japan.
Kentaro UrataDepartment of Complete Denture Prosthodontics, Nihon University School of Dentistry, 1-8-13, Kandasurugadai, Chiyoda-Ku, Tokyo, 101-8310, Japan.
Junjun NiKey Laboratory of Molecular Medicine and Biotherapy in the Ministry of Industry and Information Technology, Department of Biology, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.
Koichi IwataDepartment of Physiology, Nihon University School of Dentistry, 1-8-13, Kandasurugadai, Chiyoda-Ku, Tokyo, 101-8310, Japan.
Tatsuo ShirotaDepartment of Oral and Maxillofacial Surgery, Showa University School of Dentistry, 2-1-1 Kitasenzoku, Ota-ku, Tokyo, 142-8515, Japan.
Masamichi ShinodaDepartment of Physiology, Nihon University School of Dentistry, 1-8-13, Kandasurugadai, Chiyoda-Ku, Tokyo, 101-8310, Japan.
Nihon University · JPShowa University · JPBeijing Institute of Technology · CNMinistry of Industry and Information Technology · CN

Funding

Japan Society for the Promotion of Science 19K10049Japan Society for the Promotion of Science 20K18678Japan Society for the Promotion of Science 22K10158Japan Society for the Promotion of Science 23K09405Nihon University Chairman of the Board of Trustees Grant (2020-2021)School of Dentistry, Nihon University Sato FundSchool of Dentistry, Nihon University Uemura Fund (UEMURA-2023-2)
6 · The paper itself

Abstract

backgroundAlthough peripheral nerves have an intrinsic self-repair capacity following damage, functional recovery is limited in patients. It is a well-established fact that macrophages accumulate at the site of injury. Numerous studies indicate that the phenotypic shift from M1 macrophage to M2 macrophage plays a crucial role in the process of axon regeneration. This polarity change is observed exclusively in peripheral macrophages but not in microglia and CNS macrophages. However, the molecular basis of axonal regeneration by M2 macrophage is not yet fully understood. Herein, we aimed to identify the M2 macrophage-derived axon regeneration factor.

methodsWe established a peripheral nerve injury model by transection of the inferior alveolar nerve (IANX) in Sprague-Dawley rats. Transcriptome analysis was performed on the injured nerve. Recovery from sensory deficits in the mandibular region and histological reconnection of IAN after IANX were assessed in rats with macrophage depletion by clodronate. We investigated the effects of adoptive transfer of M2 macrophages or M2-derived cathepsin S (CTSS) on the sensory deficit. CTSS initiating signaling was explored by western blot analysis in IANX rats and immunohistochemistry in co-culture of primary fibroblasts and Schwann cells (SCs).

resultsTranscriptome analysis revealed that CTSS, a macrophage-selective lysosomal protease, was upregulated in the IAN after its injury. Spontaneous but partial recovery from a sensory deficit in the mandibular region after IANX was abrogated by macrophage ablation at the injured site. In addition, a robust induction of c-Jun, a marker of the repair-supportive phenotype of SCs, after IANX was abolished by macrophage ablation. As in transcriptome analysis, CTSS was upregulated at the injured IAN than in the intact IAN. Endogenous recovery from hypoesthesia was facilitated by supplementation of CTSS but delayed by pharmacological inhibition or genetic silencing of CTSS at the injured site. Adoptive transfer of M2-polarized macrophages at this site facilitated sensory recovery dependent on CTSS in macrophages. Post-IANX, CTSS caused the cleavage of Ephrin-B2 in fibroblasts, which, in turn, bound EphB2 in SCs. CTSS-induced Ephrin-B2 cleavage was also observed in human sensory nerves. Inhibition of CTSS-induced Ephrin-B2 signaling suppressed c-Jun induction in SCs and sensory recovery.

conclusionsThese results suggest that M2 macrophage-derived CTSS contributes to axon regeneration by activating SCs via Ephrin-B2 shedding from fibroblasts.

Indexed as

AxonsPeripheral Nerve InjuriesAnimalsCathepsinsEphrin-B2FibroblastsHumansMacrophagesNerve RegenerationPeripheral NervesRatsRats, Sprague-DawleySchwann Cellscathepsin SCathepsinsEphrin-B2Axon regenerationCathepsin SEphrin-B2Gene expressionMacrophagePeripheral nerve injurySchwann cells

Identifiers

PMID37946211
PMCPMC10636844
OpenAlexW4388525253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.